Cerebrolysin

Cerebrolysin is a preparation derived from porcine brain tissue through an enzymatic process. The resulting substance is a mixture composed of low molecular weight peptides (up to 10 kDa) and free amino acids.

The name Cerebrolysin is also used for a pharmaceutical drug product manufactured by EVER Neuro Pharma, which has been studied and is available in some countries. The material sold here is intended solely for laboratory research purposes and is not the approved pharmaceutical drug.

Neurotrophic Concept

The study of this material is related to the neurotrophic hypothesis, which posits that brain-derived growth factors are involved in neuronal maintenance, differentiation, and synaptic plasticity. This preparation contains a complex mixture of peptides and amino acids.

The peptide fraction contains fragments with structural similarities to neurotrophic factors such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF). It is hypothesized that these components may interact with multiple neurotrophin receptor systems.

In various experimental models, Cerebrolysin has been observed to influence multiple cellular pathways relevant to neuronal function.

Neurotrophic Signaling

In vitro studies suggest the peptide mixture can activate neurotrophin receptor signaling pathways, such as TrkA and TrkB receptors. Activation of these receptors is linked to intracellular cascades including the PI3K/Akt and MAPK/ERK pathways, which are involved in cell signaling related to cell survival and plasticity.

Anti-Apoptotic Effects

In some cellular models of stress, Cerebrolysin has been reported to modulate markers associated with apoptosis. These observations include changes in the expression of Bcl-2 family proteins, caspase activity, and mitochondrial membrane integrity.

Synaptic Plasticity

Research has examined the effects of this peptide mixture on synaptic structure and function. Studies in neuronal cultures have reported observations of altered dendritic branching and spine density. Effects on long-term potentiation (LTP) have also been investigated in electrophysiological studies.

Neuroinflammation Modulation

In cell culture and animal models of neuroinflammation, Cerebrolysin has been observed to modulate microglial activation and the production of cytokines such as IL-1β, IL-6, and TNF-α.

Metabolic Influence

The material has been studied for its influence on neuronal energy metabolism, with research investigating its effects on glucose utilization and mitochondrial function in the context of experimental models of ischemia and hypoxia.

Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

Laboratory Handling

Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

Research Limitations

Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.